Ceribell Names Joshua Copp as Chief Operating Officer
Copp comes to the company from McKinsey & Co.
Ceribell announced that it has named Joshua Copp as its new chief operating officer.
In a press release, Ceribell co-founder and CEO Jane Chao, PhD, said, “Joshua's leadership within McKinsey & Co.'s Medical Device Division provides him with a wealth of expertise that he will now bring to our team. His professional experience driving growth and shaping markets with clients aligns seamlessly with Ceribell's vision to make Ceribell the standard of care in seizure management."
Ceribell developed an AI-powered point-of-care EEG diagnostic system and is working to improve seizure management in acute care.
"Ceribell stands at the forefront of medical technology, reshaping the landscape of neurodiagnostics," said Joshua Copp in the press release. "I look forward to working alongside this innovative team to enable hospitals to optimize workflows and save lives."
Source
(Oct. 2, 2023); Ceribell Inc.; Ceribell Appoints Joshua Copp as Chief Operating Officer; https://www.prnewswire.com/news-releases/ceribell-appoints-joshua-copp-as-chief-operating-officer-301943415.html
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Ebglyss Demonstrates Sustained Efficacy in Moderate-to-Severe Atopic Dermatitis
March 7th 2025Clinical trial results found that a majority of patients with atopic dermatitis who were treated with Ebgylss achieved complete or near complete skin clearance at three years on a single monthly maintenance dose.
